•   Home
• About Us
• Equity
• Derivatives
• Currency
• IPO
• Mutual Funds
• NRI Corner
• Depository
• Membership
•   Contact Us 

• Market Tracker
• Company Information
•   Corporate Actions
• News Analysis
• Other Markets

Profit and Loss

Solara Active Pharma Sciences Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln BSE Code ISIN Demat Book Value(R) NSE Symbol Div & Yield % Market Cap (Rs.Cr) P/E(TTM) EPS(TTM) Face Value(R) 541540 INE624Z01016 301.3885338 SOLARA 0 2267.47 0 0 10

Mar 2024 (Rs.Cr) Mar 2023 (Rs.Cr) Mar 2022 (Rs.Cr) Mar 2021 (Rs.Cr) Mar 2020 (Rs.Cr) Mar 2019 (Rs.Cr) INCOME :             Sales Turnover 1288.92 1443.81 1268.34 1616.88 1321.75 1386.68 Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00 Net Sales 1288.92 1443.81 1268.34 1616.88 1321.75 1386.68 Other Income 5.37 22.14 18.76 28.41 27.51 12.03 Stock Adjustments -39.27 -7.05 258.75 2.15 54.16 33.79 Total Income 1255.02 1458.90 1545.85 1647.44 1403.42 1432.50 EXPENDITURE :             Raw Materials 765.75 781.78 912.64 726.56 653.03 738.62 Power & Fuel Cost 122.56 107.95 93.70 85.42 77.68 79.35 Employee Cost 243.92 228.05 234.20 227.63 202.24 183.98 Other Manufacturing Expenses 109.31 90.76 97.87 91.19 89.50 91.58 Selling & Administrative Expenses 70.40 67.50 76.39 76.07 74.19 64.70 Miscellaneous Expenses 222.41 26.68 35.43 26.83 22.74 48.38 Less : Pre-operative Expenses Capitalised 0.00 0.00 0.00 0.00 0.00 0.00 Total Expenditure 1534.35 1302.72 1450.23 1233.70 1119.38 1206.61 Operating Profit -279.33 156.18 95.62 413.74 284.04 225.89 Interest 105.97 90.06 75.27 84.47 77.88 82.42 Gross Profit -385.30 66.12 20.35 329.27 206.16 143.47 Depreciation 103.03 110.90 112.01 108.31 93.67 82.79 Profit Before Tax -488.33 -44.78 -91.66 220.96 112.49 60.68 Tax 0.00 -0.11 0.00 38.64 20.69 15.96 Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00 Deferred Tax 78.54 -22.46 -33.10 -38.64 -20.69 -13.95 Reported Net Profit -566.87 -22.21 -58.56 220.96 112.49 58.67 Extraordinary Items -158.84 -0.45 -4.26 1.65 -0.26 0.32 Adjusted Net Profit -408.03 -21.76 -54.30 219.31 112.75 58.35 Adjustment below Net Profit 0.56 -1.76 2.01 -2.53 -3.85 -10.70 P & L Balance brought forward 250.04 274.01 341.34 142.65 49.67 1.70 Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00 Appropriations 0.00 0.00 10.78 19.74 15.66 0.00 P & L Balance carried down -316.27 250.04 274.01 341.34 142.65 49.67 Dividend 0.00 0.00 0.00 0.00 0.00 0.00 Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00 Equity Dividend % 0.00 30.00 0.00 70.00 20.00 50.00 Dividend Per Share(Rs) 0.00 3.00 0.00 7.00 2.00 5.00 Earnings Per Share-Unit Curr -157.46 -6.17 -16.27 61.50 41.90 22.77 Earnings Per Share(Adj)-Unit Curr -145.12 -5.69 -15.00 56.68 38.62 20.99 Book Value-Unit Curr 260.39 417.54 424.18 443.30 370.50 333.12 Book Value(Adj)-Unit Curr 239.98 384.83 390.94 408.56 341.46 307.01